Trade Summary

1 week ago, Manning Meredith, serving as Chief Commercial Officer at Soleno Therapeutics Inc (SLNO), sold 7,522 shares at $30.44 per share, for a total transaction value of $228,980.00. Following this transaction, Manning Meredith now holds 64,507 shares of SLNO.

This sale represents a 10.00% decrease in Manning Meredith's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, March 27, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, March 31, 2026, 4 days after the trade was made.

Soleno Therapeutics Inc operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.